New from Ten Ten Ten: The 340B ‘Atom Bomb’ That Isn’t.

CMS’s proposed 2027 outpatient rule has prompted dire warnings from the hospital lobby. Our latest analysis follows the money and finds a more complicated reality.

The proposal would pay for 340B drugs closer to their actual acquisition cost, expand site-neutral payment, and save Medicare beneficiaries and taxpayers an estimated $5.7 billion in 2027. Yet the rule is imperfect: without careful protections, it could also harm genuine safety-net hospitals operating on thin or negative margins.

Ten Ten Ten outlines a more precise approach: price drugs according to their real cost, protect hospitals doing the true safety-net work, and ensure 340B discounts reach the vulnerable patients the program was created to serve.

Read The 340B ‘Atom Bomb’ That Isn’t. (https://substack.com/@tententenorg/p-206356687)